NEWSROOM

Insights, events, and firm news for life sciences, pharmaceutical, chemical, and technology innovators.

AI Is Speeding Up Drug Discovery. Your IP Strategy Is Still Moving at Yesterday’s Pace

AI is accelerating drug discovery and compressing the timeline for critical intellectual property decisions. This article explores how biotech and pharmaceutical companies can build stronger patent strategies, documentation practices, and decision frameworks to protect innovation and long-term enterprise value.

Read More